Patent details

Basic Information

Publication number:

EP2358361

PCT Application Number:

PCT/EP/2009/065270

Type:

European Patent Granted for LU

Legal Status:

Lapsed

Application number:

EP097528251

PCT Publication Number:

WO/2010/057869

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

PROLONGED RELEASE FORMULATIONS COMPRISING AN 2-OXO-1-PYRROLIDINE DERIVATE

French Title of Invention:

FORMULES À LIBÉRATION PROLONGÉE COMPRENANT UN DÉRIVÉ DE 2-OXO-1-PYRROLIDINE

German Title of Invention:

FORMULIERUNGEN ENTHALTEND EIN 2-OXO-1-PYRROLIDIN-DERIVAT MIT VERLÄNGERTER FREISETZUNG

SPC Number:

Dates

Filing date:

17/11/2009

Grant date:

14/09/2016

EP Publication Date:

14/09/2016

PCT Publication Date:

27/05/2010

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

24/08/2011

EP B1 Publication Date:

14/09/2016

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

17/11/2016

Expiration date:

17/11/2029

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

17/11/2009

 

 

Name:

UCB Biopharma SPRL

Address:

Allée de la Recherche 60, 1070 Brussels, Belgium (BE)

Inventor

1

Name:

EECKMAN Frederic

Address:

Belgium (BE)

2

Name:

FANARA Domenico

Address:

Belgium (BE)

3

Name:

BERWAER Monique

Address:

Belgium (BE)

Priority

1

Priority Number:

08105817

Priority Date:

18/11/2008

Priority Country:

European Patent Office (EPO) (EP)

2

Priority Number:

09100311

Priority Date:

02/06/2009

Priority Country:

European Patent Office (EPO) (EP)

Classification

Main IPC Class:

A61K 9/50;

Annual Fees

Annual Fee Due Date:

Annual Fee Number:

Expected Payer:

Last Annual Fee Payment Date:

Last Annual Fee Paid Number:

Payer:

Filing date	Document type	Number of pages